| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.01 | $40.08 (0%) | 🛒 Add to cart |
| 20 | $3.01 | $80.16 $60.12 (25%) | 🛒 Add to cart |
| 30 | $2.34 | $120.23 $70.14 (42%) | 🛒 Add to cart |
| 60 | $1.34 | $240.47 $80.16 (67%) | 🛒 Add to cart |
| 90 | $1.00 | $360.70 $90.17 (75%) | 🛒 Add to cart |
| 120 | $0.83 | $480.93 $100.19 (79%) | 🛒 Add to cart |
| 180 | $0.75 | $721.40 $135.26 (81%) | 🛒 Add to cart |
| 270 | $0.67 | $1082.10 $180.35 (83%) | 🛒 Add to cart |
| 360 | $0.58
Best per pill | $1442.80 $210.41 (85%) | 🛒 Add to cart |
Similar products
More info:
zyban
Zyban, known generically as bupropion hydrochloride, is a prescription medication primarily indicated as an aid to smoking cessation treatment. It’s a norepinephrine-dopamine reuptake inhibitor (NDRI) that works differently from nicotine replacement therapies. What’s fascinating is we originally developed it as an antidepressant - the same molecule as Wellbutrin - but noticed something interesting during clinical trials. Patients kept reporting they’d lost interest in cigarettes, even when we weren’t studying smoking cessation.
Bupron SR: Sustained Mood Stabilization and Smoking Cessation Support - Evidence-Based Review
Bupron SR is a sustained-release formulation of bupropion hydrochloride, primarily indicated for the management of major depressive disorder and as an aid to smoking cessation treatment. Unlike immediate-release formulations, this extended-release delivery system maintains stable plasma concentrations over 24 hours, potentially improving tolerability while maintaining therapeutic efficacy. The SR designation indicates this specialized release profile, which represents a significant advancement in antidepressant delivery systems. 1. Introduction: What is Bupron SR? Its Role in Modern Medicine When we talk about Bupron SR in clinical practice, we’re discussing a second-generation antidepressant that’s carved out a unique niche since its development in the late 1980s.
Bupropion: Effective Depression and Smoking Cessation Treatment - Evidence-Based Review
Bupropion is an atypical antidepressant belonging to the aminoketone class, structurally distinct from SSRIs and TCAs. Initially developed in 1969 and approved by the FDA in 1985, it functions primarily as a norepinephrine-dopamine reuptake inhibitor (NDRI) with minimal serotonergic activity. This unique mechanism underlies its clinical applications beyond depression, including smoking cessation and off-label uses for ADHD and sexual dysfunction. Unlike many antidepressants, bupropion is associated with weight neutrality or modest weight loss and lacks sexual side effects, making it particularly valuable for specific patient populations.
wellbutrin
Bupropion hydrochloride, marketed under the brand name Wellbutrin, represents a unique class of antidepressant medication that has fundamentally changed how we approach depression treatment. Unlike traditional SSRIs that primarily target serotonin, this molecule works through dopamine and norepinephrine pathways, creating a distinct clinical profile that’s particularly valuable for patients who can’t tolerate sexual side effects or weight gain. I’ve been prescribing this medication since the early 2000s, and watching its evolution from a novel antidepressant to a multi-indication workhorse has been one of the more fascinating journeys in my psychiatry practice.
wellbutrin sr
Bupropion SR is an extended-release formulation of the antidepressant bupropion hydrochloride, classified as an aminoketone and functioning as a norepinephrine-dopamine reuptake inhibitor (NDRI). Unlike most antidepressants that primarily target serotonin, this mechanism gives it a unique clinical profile that’s particularly valuable for patients who don’t tolerate SSRIs well or need additional benefits beyond mood regulation. I remember when we first started working with the sustained-release formulation back in the late 90s - the pharmacokinetics were a real challenge to optimize.
a ret gel
A topical retinoid formulation combining tretinoin 0.025% in a novel hydrogel delivery system designed for enhanced epidermal penetration while minimizing irritation. The gel matrix incorporates humectants and barrier-supporting ceramides to counteract the drying effects typical of traditional retinoid therapies. We initially developed this formulation after observing consistent patient complaints about the irritation and peeling associated with conventional tretinoin creams - honestly, our first three prototypes were complete failures that left our test subjects with significant erythema and scaling.
Abana: Comprehensive Cardiovascular Support Through Herbal Synergy - Evidence-Based Review
Product Description: Abana represents one of those formulations that initially seemed almost too good to be true when I first encountered it during my cardiology rotation in New Delhi back in 2004. This comprehensive herbal formulation, developed through rigorous Ayurvedic principles combined with modern pharmacological understanding, serves as a cardioprotective and lipid-normalizing agent. What struck me initially wasn’t just the ingredient list but the sophisticated delivery system that seemed to enhance bioavailability beyond what I’d seen with similar herbal preparations.
abhigra
Product Description: Abhigra is a novel dietary supplement formulation specifically engineered to address chronic inflammatory conditions through a multi-targeted approach. The product combines standardized botanical extracts with enhanced bioavailability components, designed for patients who haven’t responded adequately to conventional anti-inflammatory regimens. What makes Abhigra particularly interesting isn’t just the ingredient profile - it’s the specific ratios and delivery system that took our team nearly three years to perfect. We initially struggled with the curcuminoid stability issue - kept getting inconsistent plasma levels in our early pharmacokinetic studies.
abilify
Aripiprazole represents one of the most fascinating psychopharmacological developments of the past two decades - a third-generation antipsychotic that functions as a partial dopamine agonist rather than a pure antagonist. When I first encountered this mechanism during my residency, the concept seemed almost paradoxical: how could a medication simultaneously treat psychosis while having potential antidepressant properties? The answer lies in its unique receptor profile that allows it to act as a functional stabilizer rather than simply blocking or stimulating neurotransmitter systems.